CAD 0.01
(N/A%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -19.36 Million CAD | 50.2% |
2022 | -38.88 Million CAD | 24.24% |
2021 | -51.32 Million CAD | -265.04% |
2020 | -14.06 Million CAD | 92.98% |
2019 | -200.33 Million CAD | -456.98% |
2018 | -35.96 Million CAD | -4137.25% |
2017 | -848.86 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -11.56 Million CAD | -88.34% |
2024 Q1 | -6.13 Million CAD | 31.8% |
2023 Q2 | -2.92 Million CAD | -25.61% |
2023 Q4 | -9 Million CAD | -76.26% |
2023 FY | -19.36 Million CAD | 50.2% |
2023 Q3 | -5.1 Million CAD | -74.38% |
2023 Q1 | -2.33 Million CAD | 85.21% |
2022 Q1 | -3.33 Million CAD | 89.48% |
2022 FY | -38.88 Million CAD | 24.24% |
2022 Q3 | -6.08 Million CAD | 56.23% |
2022 Q2 | -13.91 Million CAD | -317.34% |
2022 Q4 | -15.75 Million CAD | -158.8% |
2021 Q2 | -3.89 Million CAD | 53.02% |
2021 FY | -51.32 Million CAD | -265.04% |
2021 Q1 | -8.28 Million CAD | 75.75% |
2021 Q3 | -7.47 Million CAD | -92.22% |
2021 Q4 | -31.67 Million CAD | -323.63% |
2020 FY | -14.06 Million CAD | 92.98% |
2020 Q1 | 23.51 Million CAD | 111.64% |
2020 Q4 | -34.14 Million CAD | -444.91% |
2020 Q3 | -6.26 Million CAD | -321.32% |
2020 Q2 | 2.83 Million CAD | -87.96% |
2019 Q1 | -16.11 Million CAD | -1160.88% |
2019 FY | -200.33 Million CAD | -456.98% |
2019 Q4 | -202.08 Million CAD | -53193.07% |
2019 Q3 | 380.62 Thousand CAD | -98.0% |
2019 Q2 | 19.03 Million CAD | 218.15% |
2018 Q3 | -16.09 Million CAD | -21.86% |
2018 FY | -35.96 Million CAD | -4137.25% |
2018 Q4 | 1.51 Million CAD | 109.44% |
2018 Q1 | -586.95 Thousand CAD | 47.37% |
2018 Q2 | -13.21 Million CAD | -2150.68% |
2017 FY | -848.86 Thousand CAD | 0.0% |
2017 Q3 | -339.93 Thousand CAD | 0.0% |
2017 Q4 | -1.11 Million CAD | -228.07% |
Name | Net Income | Net Income Difference |
---|---|---|
Aion Therapeutic Inc. | -6.28 Million CAD | -208.028% |
Ayurcann Holdings Corp. | -3.96 Million CAD | -388.095% |
Blueberries Medical Corp. | -1.63 Million CAD | -1084.212% |
The BC Bud Corporation | -1.22 Million CAD | -1482.142% |
BioNxt Solutions Inc. | -7.72 Million CAD | -150.764% |
CordovaCann Corp. | -6.88 Million CAD | -181.296% |
Christina Lake Cannabis Corp. | -4.13 Million CAD | -368.71% |
Captor Capital Corp. | -11.38 Million CAD | -70.164% |
City View Green Holdings Inc. | -2.44 Million CAD | -690.916% |
1CM Inc. | -913.85 Thousand CAD | -2019.183% |
Global Hemp Group Inc. | -2.58 Million CAD | -650.476% |
Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -310.072% |
IM Cannabis Corp. | -9.49 Million CAD | -103.899% |
Lobe Sciences Ltd. | -4.7 Million CAD | -311.406% |
Maple Leaf Green World Inc. | -1.09 Million CAD | -1674.239% |
Mountain Valley MD Holdings Inc. | -7.67 Million CAD | -152.494% |
Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 8771.453% |
Ovation Science Inc. | -813.14 Thousand CAD | -2281.642% |
Pharmadrug Inc. | -13.2 Million CAD | -46.7% |
Captiva Verde Wellness Corp. | -6.08 Million CAD | -218.257% |
RAMM Pharma Corp. | -7.72 Million CAD | -150.829% |
RIV Capital Inc. | -106.76 Million CAD | 81.86% |
Revive Therapeutics Ltd. | -5.61 Million CAD | -244.681% |
Red White & Bloom Brands Inc. | -138.89 Million CAD | 86.057% |
1933 Industries Inc. | -13.36 Million CAD | -44.915% |
Red Light Holland Corp. | -7.62 Million CAD | -153.908% |
Top Strike Resources Corp. | -1.72 Million CAD | -1025.927% |
Xebra Brands Ltd. | -1.95 Million CAD | -889.399% |
Adastra Holdings Ltd. | -3.54 Million CAD | -446.354% |